학술논문
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, December 2021, 163(3):473-480)
Subject
Language
English
ISSN
10956859
00908258
00908258